Shiseido continues to invest in dermo-cosmetics brands. The Japanese company made official before the end of 2023 its agreement to close the acquisition of Dr. Dennis Gross Skincare and incorporate it into its portfolio of brands.
Also known by its acronym DDG, it is a brand based in the United States and is a brand recognised on the other side of the ocean for being a prestigious cosmetic brand dedicated to skin care and which bases its effectiveness on science and is led by expert dermatologists.
Shiseido has seen the deal as an opportunity for future growth, as well as to specialise and include brands dedicated to dermo-cosmetics, thus broadening its range and enriching its brand portfolio. In the press release issued by the Japanese luxury cosmetics company, they have also acknowledged that this will serve to increase both growth and profit in the Americas: "this move will also serve to grow and record significant growth in the expanding American business, a strategically important region for Shiseido", they admit in the press release. Finally, the purchase of Dr. Dennis Gross Skincare will also help to strengthen and enhance different areas of the company such as innovation and drive the overall growth of the business.
The brand recently acquired by Shiseido was founded in 2020 by the then researcher and dermatologist focused on the study of skin cancer. The Japanese giant has highlighted the effectiveness of the active ingredients used in the formula of the products and the philosophy that has accompanied the brand since its inception: research, dermatology and technology.
Shiseido CEO Masahiko Uotani also explained that the deal is in line with the Japanese company's 2030 goals. One of the company's goals is to become a benchmark in wellness and beauty that helps people identify beauty as something special and unique that can accompany them throughout their lives.